文献速递肝胆胰外科围术期管理与 ERAS

远端胰腺切除术的基准结局:西班牙远端胰腺切除术项目(SPANDISPAN)的多中心前瞻性快照研究

Benchmark Outcomes for Distal Pancreatectomy: A Multicenter Prospective Snapshot Study from the Spanish Distal Pancreatectomy Project (SPANDISPAN).
PubMed 文献 · J Am Coll Surg · 2024-08-15

该研究为西班牙肝胆胰中心为期一年的前瞻性多中心观察性快照研究,纳入313例远端胰腺切除术患者,确定基准值:主要并发症21.1%,B/C级术后胰瘘20.1%,90天死亡率1.6%,微创手术占69.3%。与既往基准数据相比,微创率更高、住院时间更短。

要点

  • 多中心前瞻性研究确定远端胰腺切除术基准值:主要并发症21.1%,B/C级胰瘘20.1%,90天死亡率1.6%。
  • 微创手术占69.3%,与既往基准相比微创率增加且住院时间更短。
  • 基准是多参数工具,可用于报告结局、比较中心和识别改进点。

核心结论

  • 首次在前瞻性系列中确定远端胰腺切除术基准值,结果与既往基准相似,但住院时间更短、微创手术比例更高,可能与加速康复外科方案和前瞻性数据收集有关。
  • 基准是多参数有价值的工具,用于报告结局、比较中心和识别改善外科治疗的要点。

研究设计与样本

  • 前瞻性、多中心、观察性快照研究,在西班牙肝胆胰中心开展,时间为2022年2月1日至2023年1月31日,为期一年。
  • 肝胆胰中心每年实施超过10例远端胰腺切除术定义为高容量中心。
  • 纳入标准为任何诊断的择期远端胰腺切除术且年龄大于18岁。
  • 低风险组按Durin等提出的标准定义,主要并发症定义为Clavien-Dindo ≥III级。
  • 共纳入来自42个中心的313例患者,46.6%来自高容量中心。

主要发现

  • 中心远端胰腺切除术中位数为7例(四分位距5至10)。
  • 中位年龄65岁(四分位距55至74),女性占53.4%。
  • 微创手术方式占69.3%。
  • 主要并发症为21.1%,术后B/C级胰瘘率为20.1%,90天死亡率为1.6%。
  • 低风险组143例(43.8%);与既往基准数据相比,微创手术率增加且住院时间更少。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Improving the quality of care is a priority for health systems to obtain better care and reduce costs. One of the tools for measuring quality is benchmarking (BM). We presented a 1-country prospective study of distal pancreatectomies (DPs) and determined BM. STUDY DESIGN: Prospective, multicenter, observational snapshot study of DP carried out at Spanish hepatopancreatobiliary centers for a year (February 1, 2022, to January 31, 2023). Hepatopancreatobiliary centers were defined as high volume if they performed more than 10 DPs per year. Inclusion criteria include any scheduled DP for any diagnosis and age older than 18 years. The low-risk group was defined following the criteria given by Durin and colleagues and major complications as Clavien-Dindo ≥III. RESULTS: A total of 313 patients from 42 centers and 46.6% from high-volume centers were included. Median DP by center was 7 (interquartile range 5 to 10), median age was 65 years (interquartile range 55 to 74), and 53.4% were female. The surgical approach was minimally invasive in 69.3%. Major complications were 21.1%. Postoperative pancreatic fistula grade B/C rate was 20.1%, and 90-day mortality was 1.6%. One hundred forty-three patients were in low-risk group (43.8%). Compared with previous BM data, an increasing MIS rate and fewer hospital stay were obtained. CONCLUSIONS: We present the first determination of DP-BM in a prospective series, obtaining similar results to the previous ones, but our BM values include a shorter hospital stay and a higher percentage of minimally invasive surgery probably related to Enhanced Recovery after Surgery protocols and prospective data collection. BM is a multiparameter valuable tool for reporting outcomes, comparing centers, and identifying the points to improve surgical care.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Ramia JM, Alcázar-López CF, Villodre-Tudela C, et al. Benchmark Outcomes for Distal Pancreatectomy: A Multicenter Prospective Snapshot Study from the Spanish Distal Pancreatectomy Project (SPANDISPAN). J Am Coll Surg. 2024. PMID: 38533997. doi:10.1097/XCS.0000000000001086

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。